The objective of this paper is to describe history of hyperthermia and its clinical applications in cancer treatment. Hyperthermia is a promising approach for cancer therapy which is used to increase the temperature of body tissue by delivering heat obtained from external sources to destroy cancerous cells with minimal or no damaging healthy tissues. There are three main clinical applications of hyperthermia such as local, regional and whole body. Microwaves, radiofrequency, ultrasound, infrared and different kinds of hot sources (hot water, ferromagnetic, nanoparticles) heating approaches are used in some clinical trials. Hyperthermia is administered as an adjuvant to other cancer treatment modalities (multimodal oncological strategies). However, hyperthermia is still facing many challenges in cancer treatment. Some trials continue to use hyperthermia in combination with other novel interstitial technologies such as magnetic fluid hyperthermia and thermolabile liposomes, application of therapeutic monoclonal antibodies under hyperthermic conditions, and hyperthermiainduced gene therapy for the treatment of different cancers which have been discussed. Thus, progress of hyperthermia in clinical applications has already shown some benefits to cancer patients.
Introduction
Worldwide, cancer is a leading cause of death. Hyperthermia is a promising approach to cancer therapy (van der Zee, 2002) . It is used to raise the temperature of a region of the body affected by cancer up to 41.5-43°C with minimal or no damaging of healthy tissues, using external and internal heating devices. It is applied together with conventional approaches such as radiotherapy and chemotherapy in the treatment of cancer patients. It is proposed that by killing cancer cells and damaging proteins and structures within the cells, hyperthermia may shrink tumors, making the cells more sensitive to radiation therapy (RT) or chemotherapy (American Cancer Society, 2009 ). The increase of temperature, required can be achieved by various methods. Therapeutic potentials, expenditure of treatment, technical problems and evidence of effectiveness are diverse, based on the different hyperthermia approaches. There are three main clinical applications of hyperthermia such as local, regional and whole body. Results from studies on laboratory animal models and initial human clinical trials have been very promising and suggest that hyperthermia may have a vital role in future cancer treatment. This paper presents an overview of clinical and practical application of hyperthermia.
History
The application of heat to treat disease dates back to ancient times but took its modern form only in the last 20 years. In India, the clinical use of hyperthermia in the system of traditional medicine (Ayurveda) applied around 3000 years ago. It formed part of a clinical protocol developed called "Panchakarma" that was used in curative and preventive medicine. The first recorded uses of localized hyperthermia for cancer treatment appeared in the writings of Ramajama (2,000 B.C.)
Combination of hyperthermia and radiotherapy
Hyperthermia is considered to be one of the most potent radio-sensitizers (Lindner and Issels, 2011) . Ionizing radiation generates free oxygen radicals which will attack the DNA of tumour cells. This is the primary mechanism of radiotherapy. In spite of the cancer cells low in oxygen and pH range or in S-phase, are relatively radio-resistant (Jones et al., 2005) . This is where hyperthermia may need as a supplementary for radiation therapy. Table 1 shows combination of hyperthermia and radiotherapy. This proved that heat enhances the cell killing through direct thermal toxicity and shows thermal enhancement of drug efficacy (Issels, 2008) . This is due to heat that can alter tumour cell membrane permeability for the penetration of chemotherapeutic drugs into tissues and absorption by the tumour. Table 2 shows clinical trials of hyperthermia in combination with chemotherapy that have been done in cancer patients. Di Giorgio, A., Naticchioni, E., Biacchi, D., Sibio, S., Accarpio, F., Rocco, M., Tarquini Mitsumori, M., Zhi-Fan, Z., Oliynychenko, P., Park, J.H., Choi, I.B., Tatsuzaki, H., Tanaka, Y. & Hiraoka, M. (2007) . Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. International Journal of Clinical Oncology, 12(3), 192-198. Overgaard, J., Gonzalez, D.G., Hulshof, M.C.C.H., Arcangeli, G., Dahl, O., Mella, O. & Bentzen, S.M. (1996) 
